Haihe Biopharma Co., Ltd
谷美替尼片, Glumetinib Tablet, Haiyitan, SCC244, 50mg*24 Tablets, Oral Selective MET Inhibitor for MET-Altered Advanced NSCLC: Targeting Exon 14 Skipping & MET Overexpression (IHC 3+)
谷美替尼片, Glumetinib Tablet, Haiyitan, SCC244, 50mg*24 Tablets, Oral Selective MET Inhibitor for MET-Altered Advanced NSCLC: Targeting Exon 14 Skipping & MET Overexpression (IHC 3+)
Couldn't load pickup availability
Gumarontinib tablet
50mg 24pieces/box
Indication:
For the treatment of adult patients with locallyadvanced or metastatic non-small cell lung cancer withMET exon 14 skipping mutations
Gumarontinib is an oral, potent and highly selectivesmall molecule MET inhibitor which global intellectual property rights is owned by Haihe Biopharma. The mechanism of action is to inhibit MET kinase activitypotently and specifically.It has demonstrated clear efficacy benefit in the patientgroup with brain metastases.
If you are seeking additional discounts or have an interest in purchasing other Chinese medications, please feel free to contact us at any time. We are fully dedicated to offering you comprehensive services tailored to your individual needs.
Share
